These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Assessment of disease activity in a registry of Crohn's disease patients in eastern Pennsylvania. Reed JF, Faust LA, Rosen L. Z Gastroenterol; 1991 Aug; 29(8):378-82. PubMed ID: 1950050 [Abstract] [Full Text] [Related]
4. Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease. Thia KT, Sandborn WJ, Lewis JD, Loftus EV, Feagan BG, Steinhart AH, Hanauer SB, Persson T, Sands BE. Am J Gastroenterol; 2008 Dec; 103(12):3123-31. PubMed ID: 18786111 [Abstract] [Full Text] [Related]
5. Crohn's disease. Pilot study comparing MRI of the abdomen with clinical evaluation. Kettritz U, Isaacs K, Warshauer DM, Semelka RC. J Clin Gastroenterol; 1995 Oct; 21(3):249-53. PubMed ID: 8648064 [Abstract] [Full Text] [Related]
6. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease. Winterkamp S, Weidenhiller M, Otte P, Stolper J, Schwab D, Hahn EG, Raithel M. Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192 [Abstract] [Full Text] [Related]
7. A survey-based index was validated for measuring disease activity in inflammatory bowel disease. An evaluation study. Timmer A, Kemptner D, Takses A, Klebl F, Jöckel KH. J Clin Epidemiol; 2009 Jul; 62(7):771-8. PubMed ID: 19110402 [Abstract] [Full Text] [Related]
8. Comparison between prospective and retrospective evaluation of Crohn's disease activity index. Frenz MB, Dunckley P, Camporota L, Jewell DP, Travis SP. Am J Gastroenterol; 2005 May; 100(5):1117-20. PubMed ID: 15842587 [Abstract] [Full Text] [Related]
9. [Serum level of TNF-alpha receptor type II better correlates with severity of Crohn's disease than other cytokines and conventional clinical activity indicators]. Kohut M, Kacperek-Hartleb T, Sojka D, Hartleb M. Pol Merkur Lekarski; 2010 Jun; 28(168):454-8. PubMed ID: 20642103 [Abstract] [Full Text] [Related]
11. Prospective assessment of Cleveland Global Quality of Life (CGQL) as a novel marker of quality of life and disease activity in Crohn's disease. Kiran RP, Delaney CP, Senagore AJ, O'Brien-Ermlich B, Mascha E, Thornton J, Fazio VW. Am J Gastroenterol; 2003 Aug; 98(8):1783-9. PubMed ID: 12907333 [Abstract] [Full Text] [Related]
12. [Quantifying the inflammatory activity in Crohn's disease using CE dynamic MRI]. Pauls S, Kratzer W, Rieber A, Schmidt SA, Mittrach C, Adler G, Brambs HJ, Gabelmann A. Rofo; 2003 Aug; 175(8):1093-9. PubMed ID: 12886478 [Abstract] [Full Text] [Related]
13. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis. Niederau C, Backmerhoff F, Schumacher B, Niederau C. Hepatogastroenterology; 1997 Aug; 44(13):90-107. PubMed ID: 9058126 [Abstract] [Full Text] [Related]
14. Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease. Gelbmann CM, Rogler G, Gross V, Gierend M, Bregenzer N, Andus T, Schölmerich J. Am J Gastroenterol; 2002 Jun; 97(6):1438-45. PubMed ID: 12094862 [Abstract] [Full Text] [Related]
15. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Best WR, Becktel JM, Singleton JW. Gastroenterology; 1979 Oct; 77(4 Pt 2):843-6. PubMed ID: 467941 [Abstract] [Full Text] [Related]